SYNAPS Dx
PrivateLast Round
Series A
Oct 12, 2021
Total Funding Raised
$10M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
SYNAPS Dx is a diagnostics company that researches, develops, and commercializes diagnostics for neurodegenerative disorders, including its primary product DISCERN™, a minimally invasive test for the definitive diagnosis of Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SYNAPS Dx Comparables
Compare SYNAPS Dx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CND Life Sciences | 80% | |
| C2N Diagnostics | 78% | |
| Labcorp | 72% |
SYNAPS Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 12, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 147% MoM, reaching 2.3K.
- Jul 26, 2026
Monthly visitors increased 2041% MoM, from 44 to 942.
SYNAPS Dx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SYNAPS Dx's valuation, stock price, and market status.
Is SYNAPS Dx a public or private company?
SYNAPS Dx is a private company.
What is the current stock price of SYNAPS Dx?
SYNAPS Dx is a private company with no public stock price. No recent secondary market data is available.
How much is SYNAPS Dx worth (valuation)?
Valuation information for SYNAPS Dx is not publicly available.
Can I buy SYNAPS Dx stock?
SYNAPS Dx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SYNAPS Dx's last funding round?
SYNAPS Dx's most recent funding round was Series A on October 12, 2021.
Who are the main investors in SYNAPS Dx?
Investor information for SYNAPS Dx is not publicly disclosed.
Will SYNAPS Dx IPO soon?
No public IPO plans have been announced for SYNAPS Dx.
How can I track SYNAPS Dx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SYNAPS Dx's secondary market activity and sign up for updates.